ANDA 203928, held by Strides Pharma. Polyethylene Glycol 3350.
As of Nov 16, 2026, ANDA 203928 (Polyethylene Glycol 3350), held by Strides Pharma, was first approved by FDA on Aug 24, 2016, with 3 approved supplements and 0 published complete response letters.
Use relieves occasional constipation (irregularity) generally produces a bowel movement in 1 to 3 days
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 24, 2016 | Original application | Approved | None posted |
| Polyethylene Glycol 335017GM/SCOOPFUL · for solution;oral | Polyethylene Glycol 3350 | OTC |
| Polyethylene Glycol 335017GM/PACKET · for solution;oral | Polyethylene Glycol 3350 | OTC |
| Sep 11, 2026 | Supplement 19Manufacturing | Approved | None posted |
| Feb 8, 2023 | Supplement 5Labeling · Standard review | Approved | None posted |
| Feb 8, 2023 | Supplement 11Labeling · Standard review | Approved | None posted |
| Aug 24, 2016 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters